Enhanced permeability and retention (EPR) effect: Advances in nanomedicine for improved tumor targeting
Biomaterials Advances · 2026-04 · 181 · 214636
DOI: 10.1016/j.bioadv.2025.214636 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomaterials Advances, 2026-04. Verfasst von Mohammad Sameer Khan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India. Hauptthemen laut MEDLINE: Neoplasms, Nanomedicine, Drug Delivery Systems, Antineoplastic Agents. Die Arbeit wurde bisher 114-mal zitiert (Crossref) und nennt 94 Literaturangaben. Gefördert von: Deanship of Scientific Research, King Khalid University.
Abstract (Originalsprache)
The enhanced permeability and retention (EPR) effect driven by abnormal tumor vasculature and impaired lymphatic drainage has long been considered a cornerstone of nanomedicine-based cancer therapy. While preclinical studies demonstrate substantial nanoparticle accumulation in solid tumors via passive targeting, clinical outcomes remain inconsistent due to the heterogeneous and dynamic nature of the EPR effect across tumor types and patients. Tumor vascular density, elevated interstitial fluid pressure, and stromal barriers frequently restrict drug penetration and retention, limiting therapeutic efficacy. This review provides a critical and translational perspective on strategies to amplify the EPR effect, including vascular normalization, transient modulation of blood flow, hypertension induction, and integration with active targeting ligands. We also highlight tumor microenvironment remodeling, image-guided delivery, and patient-specific predictive diagnostics as emerging avenues to enhance clinical predictability. By bridging mechanistic insights with therapeutic innovation, we propose a roadmap to reengineer EPR-based delivery systems for more consistent, potent, and personalized nanomedicine in solid tumor management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India.
- Department of Pharmacology, College of Pharmacy, King Khalid University, Abha, 62529, Saudi Arabia.
- Department of Medical Laboratory, College of Applied medical sciences, Prince Sattam bin Abdulaziz University, Alkharj, 11942, Saudi Arabia.
- Graphic Era Hill University, Dehradun, 248002, India; School of Allied Medical Sciences, Lovely Professional University, Phagwara, Punjab, India.
- Faculty of Business and Communication, INTI International University, Nilai, Malaysia.
- Center for Global Health Research, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India.
Förderung
- Deanship of Scientific Research, King Khalid University
Zitieren
APA
Khan, M. S., Alqahtani, T., Al Shmrany, H., Gupta, G., Goh, K. W., Sahebkar, A., & Kesharwani, P. (2026). Enhanced permeability and retention (EPR) effect: Advances in nanomedicine for improved tumor targeting. Biomaterials Advances, 181, 214636. https://doi.org/10.1016/j.bioadv.2025.214636
Vancouver
Khan MS, Alqahtani T, Al Shmrany H, Gupta G, Goh KW, Sahebkar A, et al. Enhanced permeability and retention (EPR) effect: Advances in nanomedicine for improved tumor targeting. Biomaterials Advances. 2026;181:214636. doi:10.1016/j.bioadv.2025.214636
BibTeX
@article{Khan2026,
author = {Khan, Mohammad Sameer and Alqahtani, Taha and Al Shmrany, Humood and Gupta, Garima and Goh, Khang Wen and Sahebkar, Amirhossein and Kesharwani, Prashant},
title = {Enhanced permeability and retention (EPR) effect: Advances in nanomedicine for improved tumor targeting},
journal = {Biomaterials Advances},
year = {2026},
volume = {181},
pages = {214636},
doi = {10.1016/j.bioadv.2025.214636}
}
EUVIMED